Iron Sucrose Injection
Product Images NDC 76329-9201

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Iron Sucrose (NDC 76329-9201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by International Medication Systems, Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

9200carton (9200carton)

9200carton (9200carton)
This text provides information about Iron Sucrose Injection, USP, containing 50 mg of elemental iron per 2.5 mL (20 mg/mL). It indicates that the product is for intravenous use only and mentions the brand "Bocard Unisea Portion."*
FDA Label Image

9201carton (9201carton)

9201carton (9201carton)
FDA Label Image

9202carton (9202carton)

9202carton (9202carton)
Iron Sucrose Injection, USP is a medication containing 200 mg of elemental iron per 10 mL (20 mg/mL) and is provided in a 10 mL single-dose vial for intravenous use only. The drug product is manufactured by International Medication Systems, Limited, a subsidiary of Amphastar Pharmaceuticals. Each 10 mL vial contains iron sucrose in water for injection, with approximately 30% sucrose by weight and sodium chloride for isotonicity. No preservatives are included in the formulation. It is recommended to store the product at 20°C to 25°C (66°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F) and should not be frozen. The usual dosage should be determined based on prescribing information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.